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Abstract 
Introduction: Patients with diabetes may develop muscle weakness and atrophy 
of the lower limbs and are at increased risk of falling. The underlying basis of 
these abnormalities has not been fully explained. 
Aims: To objectively quantify muscle strength and size in patients with type 2 
diabetes mellitus (T2DM) in relation to the severity of neuropathy, intramuscular 
non-contractile tissue (IMNCT) and vitamin D deficiency. 
Methods: 20 patients with T2DM and 20 healthy control subjects were matched 
by age, gender and BMI. They underwent assessment of strength and size of 
knee extensor, flexor and ankle plantar and dorsiflexor muscles in relation to the 
severity of diabetic sensori-motor neuropathy (DSPN), amount of intramuscular 
non-contractile tissue and serum 25OHD levels.  
Results: Patients with T2DM had significantly reduced knee extensor (P= 0.003) 
strength and muscle volume of both knee extensors (P= 0.045) and flexors (P= 
0.019). Ankle plantar flexor strength (P=0.001) was also significantly reduced   
but without a reduction in ankle plantar flexor (P= 0.23) and dorsiflexor (P=0.45) 
muscle volumes. IMNCT was significantly increased in the ankle plantar (P= 
0.006) and dorsiflexors (P= 0.005) of patients with T2DM compared to controls. 
Patients with DSPN had significantly lower knee extensor strength compared to 
those without DSPN (P= 0.02), but there was no difference in knee extensor 
volume (P=0.38) and ankle plantar flexor strength or volume (P= 0.21 and P= 
0.96 respectively). There was no significant difference for the strength and 
volume of knee extensors (P=0.32 and P= 0.18) or ankle plantar flexors (P=0.58 
and P=0.12) between T2DM patients with a 25 hydroxyvitamin D (25OHD) 
<25nmol/L vs >25 nmol/L. 
Conclusions: Patients with T2DM have a significant reduction in proximal and 
distal leg muscle strength and a proximal but not distal reduction in muscle 
volume, possibly due to greater intramuscular fat accumulation in distal muscles. 
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Proximal but not distal muscle strength was related to the severity of peripheral 
neuropathy, but not with IMNCT or the level of 25OHD. 
Key words: Diabetes, muscle strength, muscle size, intramuscular fat, peripheral 
neuropathy, vitamin D.  
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Introduction  
Although diabetic polyneuropathy manifests primarily in the form of sensory and 
autonomic dysfunction, an increasing body of evidence shows that ankle and 
knee motor dysfunction may also be a major manifestation (1-3). Motor 
dysfunction presents as muscle weakness, a reduction in muscle mass, limitation 
of joint flexibility and range of motion, ultimately impacting upon gait and whole 
body movements (4-6).  
Whilst weakness and atrophy of the distal muscles and decreased ankle mobility 
and strength have been demonstrated in several previous studies and related to 
the severity of neuropathy (7-9) underlying mechanisms have not been explored. 
Previous studies have not performed a comprehensive assessment of muscle 
strength in relation to morphology and internal composition. Thus patients with 
diabetes and obesity have an increased amount of intramuscular non-contractile 
tissue (IMNCT) which is highly correlated to insulin resistance and a reduction of 
muscle strength in the calf and thigh muscles (1, 2, 10).  
Variations in muscle volume (11) may contribute to the alterations in strength, 
and as many patients with diabetes have obesity they may have larger muscle 
size, but the presence of diabetic neuropathy may result in muscle atrophy (7). 
Thus, previous studies have shown atrophy of the ankle plantar and dorsiflexor 
muscles as well as knee extensors in patients with diabetic neuropathy 
compared to patients without neuropathy and control subjects (2, 4, 6, 8). 
However, the effect on more proximal leg muscles (knee extensors and flexors), 
i.e. those muscles which confer a major effect on postural stability and gait 
performance is not established. Indeed maximal isometric muscle strength is 
related directly to muscle cross sectional area (11-13). 
It has been suggested that a decline of muscle strength and muscle size, with 
increased intramuscular fat infiltration and a reduction in physical performance in 
healthy elderly subjects may be related to vitamin D deficiency (14, 15). Motor 
dysfunction can occur in those with mild and particularly severe vitamin D 
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deficiency (14, 16). Furthermore, 93% of patients complain of non-specific 
musculoskeletal pain, which may be attributed to vitamin D deficiency (17). The 
degree of vitamin D deficiency is currently categorised according to circulating 
levels of 25-hydroxy vitamin D (25OHD) such that adequate is defined as: >75 
nmol/L (>30ng/ml); insufficient: 75-50 nmol/L (20-30 ng/ml); deficient: 25-
50nmol/L (10-20ng/ml) and severely deficient: <25 nmol/L (<10ng/ml) (18). The 
underlying basis of vitamin D deficiency related muscle symptoms and 
dysfunction is likely to be complex, but proximal myopathy is a major 
manifestation of those with severe vitamin D deficiency (17). Vitamin D receptors 
decline in elderly subjects (17, 19, 20) and vitamin D deficiency is associated 
with atrophy of skeletal muscle fibers (Type II) and a decline in muscle strength, 
with an increased risk of falls (17, 21). We have previously shown a high 
prevalence of vitamin D deficiency in patients with diabetes (22) and vitamin D 
levels are inversely correlated with obesity, diabetes and high triglycerides (23). 
Although previous studies have investigated specific aspects of motor function in 
patients with Type 2 diabetes, there has not been a comprehensive assessment 
of skeletal muscle strength, morphology and internal composition in relation to 
neuropathy, IMNCT and 25OHD.  
The purpose of this study was to investigate muscle strength deficits in distal and 
proximal extensors and flexors in the lower limb of patients with Type 2 diabetes 
and relate this to muscle size, the severity of peripheral neuropathy, IMNCT and 
vitamin D deficiency.  
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Methods 
20 patients with Type 2 diabetes and 20 control subjects without diabetes 
underwent assessment at the muscle function laboratory at Manchester 
Metropolitan University. Subjects with severe musculoskeletal problems, 
neurological, orthopaedic or surgical problems, severe foot deformities, foot 
ulcers, amputations and pregnant women were excluded from the study. The 
study was approved by the UK National Health Service (NHS) ethics committee, 
local Research Ethics Committees at the University of Manchester and the 
Manchester Metropolitan University and written informed consent was obtained 
from all subjects prior to participation. This research adhered to the tenets of the 
declaration of Helsinki.  
Assessment of Neuropathy 
All patients with diabetes underwent assessment of body mass index (BMI), 
blood pressure, HbA1c, lipid profile [total cholesterol, low density lipoprotein 
(LDL), high density lipoprotein (HDL) and triglycerides], albumin creatinine 
excretion ratio , estimated glomerular filtration rate  and 25 (OH)D.  Symptoms of 
DPN were assessed using the Neuropathy Symptom Profile. Neurological deficits 
were evaluated using the simplified neuropathy disability score (NDS), which is 
comprised of vibration perception, pin-prick, temperature sensation and presence 
or absence of ankle reflexes. Vibration perception threshold (VPT) was tested 
using a Neurothesiometer (Horwell, Scientific Laboratory Supplies, Wilfrod, 
Nottingham, UK). Cold (CT), warm (WT) thresholds, cold induced pain (CIP) and 
warm induced pain (WIP) were established on the dorsolateral aspect of the  foot  
using the TSA-II NeuroSensory Analyser (Medoc Ltd., Ramat-Yishai, Israel). . 
Electro-diagnostic studies were undertaken using a Dantec “Keypoint” system 
(Dantec Dynamics Ltd, Bristol, UK) equipped with a DISA temperature regulator 
to keep limb temperature constantly between 32-35°C. Sural sensory nerve 
amplitude (SNAP), sural sensory nerve conduction velocity (SNCV) and peroneal 
motor nerve conduction velocity (PMNCV) and amplitude (PMNA) were assessed 
by a consultant neurophysiologist. (Diabetic sensorimotor polyneuropathy) DSPN 
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was defined according to the Toronto criteria (24). Control subjects only 
underwent an assessment of VPT and NDS. 
All study subjects were scanned with a laser IVCCM [Heidelberg Retinal 
Tomograph III Rostock Cornea Module (Heidelberg Engineering GmbH, 
Heidelberg, Germany)]. All images were captured using the “section” mode in the 
Heidelberg Explorer of the HRT III RCM and ~6 high clarity images/subject were 
analysed from the central sub basal nerve plexus. Four parameters were 
established to assess corneal nerve fiber damage; Corneal nerve fiber density 
(CNFD): the total number of nerve fibers (no./mm2); Corneal nerve branch 
density (CNBD): the total number of nerve branches (no./mm2); Corneal nerve 
fiber length (CNFL): the total length of all nerve fibers (mm/mm2) within the area 
of cornea and Corneal nerve fiber tortuosity (CNFT): the degree of non-linearity 
of the nerve fibers. These parameters were quantified using semi-automated, 
purpose-written, proprietary software (CCMetrics®, M. A. Dabbah, Imaging 
Science Biomedical Engineering, University of Manchester, Manchester, UK). 
Intraepidermal nerve fiber density (IENFD) was quantified in skin biopsies from 
the dorsum of the foot using our established techniques (25).   
Isokinetic dynamometer (Cybex)  
Maximal isometric muscle strength for knee extensors and ankle plantar flexors 
was assessed using an isokinetic dynamometer (Cybex Norm, Ronkonkoma, 
NY). The dynamometer measured joint torque (Nm) at the knee and ankle, which 
reflects the net forces acting around the respective joints and the internal tendon 
moment arm lengths. Since this measure (joint torque) primarily reflects the force 
produced by the major muscle groups acting around these joints (knee and ankle 
extensors, respectively) and for the purpose of optimising clinical understanding, 
we use the term ‘muscle strength’ in the manuscript to refer to the measurement 
of joint torque.  
Tests were performed at three different angles for both the knee and ankle joints 
on the dominant leg. To test knee extensor joint torque, participants were seated 
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and secured on the chair of the dynamometer with their knees flexed at 90 
degrees (0 degrees = full knee extension) and their hip angle at 85 degrees (0 
degrees = supine position). Three maximal voluntary isometric contractions of the 
knee extensors were performed at 3 knee joint angles tested in a randomised 
order: 85, 70, and 55 degrees of knee flexion, with a two minute rest interval 
between contractions and the highest value was recorded.  
To test ankle plantar flexor joint torque participants were positioned prone on the 
dynamometer with the knee in full extension and the ankle secured into the 
footplate of the dynamometer. Maximum voluntary isometric plantar flexor joint 
torque was assessed at three different joint angles performed in a random order: 
0 degrees (neutral position, i.e., right angle between footplate and tibia), -5 
degree in dorsiflexion, and -10 in dorsiflexion and also three maximal isometric 
contractions were performed and the highest value was recorded (Nm). Each 
maximum isometric contraction for both knee and ankle was held for around 3-4 
seconds, with a 60 second rest interval between contractions within each angle 
and 2 minutes between contractions at different angles.  
A range of joint angles were tested to ensure that we encompassed the joint 
angle where torque peaked (i.e., the optimum angle) for each participant and that 
we therefore took into account any slight variations in the muscle’s force-length 
relationship between groups.   
Magnetic Resonance Imaging (MRI) 
A 0.25 Tesla MRI peripheral scanner (G-Scan, Esaote, Italy) was employed to 
scan the upper and lower regions of the leg with a T1 Gradient Echo scanning 
sequence with the following parameters: field of view= 200x200mm; matrix= 
256x192 pixels; slice thickness= 10mm, inter-slice gap = 1mm; time to echo=16 
ms; time to repetition = 685 ms and flip angle = 90 degrees. Serial axial plane 
images were obtained of the upper and lower leg, from which the cross-sectional 
areas (CSA) of specific muscles were analysed. Major exclusion criteria for MRI 
scanning included: women who were or could be pregnant; Ferromagnetic 
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foreign bodies; Cardiac pacemakers/cardioverter defibrillators; cochlear implants, 
Intrauterine devices and implanted drug infusion pumps.  
Muscle volume calculation 
Serial CSAs of the Knee extensors (vastus medialis, vastus intermedius, vastus 
lateralis and rectus femoris) knee flexors (semimembranosus, biceps femoris and 
semitendinosus); ankle plantar flexors (soleus, medial and lateral heads of 
gastrocnemius muscles) and ankle dorsiflexors (tibialis anterior and extensor 
digitorum longus) were analysed using digitizing software (OsiriX, Pixmeo, 
Geneva, Switzerland).  
The CSA of each muscle was manually analyzed from the serial axial plane 
scans. To establish how many CSAs were required to be analysed for each 
specific muscle to provide a representative and accurate muscle volume 
calculation, three subjects were randomly selected and all of the available CSAs 
analyzed consecutively. The muscle volume calculated using all available slices 
was then compared against calculations using measurements from every second 
and third slice. As a result of the analysis, for the soleus, ankle dorsiflexors, 
vastus medialis, vastus intermedius, vastus lateralis, semimembranosus, biceps 
femoris and semitendinosus every third slice was used and for medial and lateral 
heads of gastrocnemius and rectus femoris every slice was used in the 
calculation of muscle volume. The sum of all CSAs for each muscle was 
calculated (∑CSA cm2) and multiplied by the distance between each muscle 
section d (m) in order to derive the muscle volume (cm3) using the following 
equation:  
Muscle volume (cm3) = (∑CSA cm2* d) 
Intramuscular non-contractile tissue 
The density of different tissues is reflected by a different MRI signal intensity. 
Connective tissues yield low signal intensity values, while fat tissue produces 
very high signal intensity values, with the signal intensity of skeletal muscle 
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falling between these two tissues. By measuring the frequency distribution of the 
signal intensity from a given area of the MRI image, it is possible to determine 
shifts in signal intensity indicating changes in tissue composition. OsiriX software 
was used to measure the signal intensity for all muscles, from the region outlined 
as their CSA. The signal intensity was quantified in each of the muscles studied 
and a frequency distribution of the signal intensity in that CSA obtained. The 
signal intensity value with the highest frequency from the selected muscle CSA 
was recorded when this signal intensity value composed over 10% of the pixel 
number from the total number of pixels within that specific muscle CSA. Three 
different levels along the patient’s leg were chosen (proximal, mid and distal) 
according to the different anatomical structure of the muscle. The sum of the 
three signal intensity values from each muscle was selected and used for further 
analysis.   
Statistical Analysis 
An independent samples Student’s t-test was used to test between-group 
differences in the measured variables. A Pearson’s correlation coefficient was 
performed to test the relationship between muscle strength and other 
parameters. Data are presented as mean ± standard deviation (SD) unless 
otherwise stated. 
We have performed a power analysis before the study (a-priori power 
calculation) using the parameter ankle joint strength (torque) based upon the 
results of previous studies (7, 26) using the following equation: n = 2   ((Zα + 
Zβ) σ) / Δ)2. The power analysis indicated that we needed 14 subjects in each 
of the two groups to detect a difference of 22 Nm between the groups (~20% 
difference between groups), with an alpha level of 0.05 and a beta level of 0.9 
(i.e., power of 90%).To account for drop-out and potential data problems we 
recruited 20 into each group.         
	  
 
11	  
	  
Results 
Study Subjects 
20 healthy controls (13 males & 7 females) and 20 patients with Type 2 diabetes 
(8 patients with T2DM had DSPN and 12 had no DSPN), (15 males & 5 females) 
were assessed. Age, height and BMI were matched in patients with T2DM 
compared to control subjects (Table1). Patients with T2DM had reasonable 
control of their glycemia and lipids and evidence of mild neuropathy based on 
neurological examination, quantitative sensory testing, neurophysiology, corneal 
confocal microscopy and skin biopsy (Table 1).  
 
Muscle strength and volume 
The knee and ankle muscle strength (Nm/kg) was significantly lower in patients 
with T2DM compared to controls at three different angles.  Knee strength at 55º 
(1.3 ± 0.4 vs 2.1 ± 0.7; P=0.002), 70º (1.3 ± 0.5 vs 2.0 ± 0.8; P= 0.002) and 85º 
(1.3 ± 0.4 vs 1.8 ± 0.6; P=0.009) was significantly reduced in patients with T2DM 
compared to control subjects. Ankle strength at 0º (0.6 ± 0.2 vs 0.9 ±0.3; 
P=0.000), -5º (0.7 ± 0.2 vs 1.04 ± 0.3; P=0.001) and -10º (0.7 ± 0.2 vs 1.1 ± 0.36; 
P=0.001) was significantly reduced in patients with T2DM compared to control 
subjects. Accordingly the average knee extensor (1.3±0.5 vs 1.9±0.7; P=0.003) 
and ankle plantar flexor (0.6±0.2 vs 1.05±0.3; P= 0.001) strength was 
significantly lower in patients with T2DM compared to controls (Table 2).  
Muscle volume 
Muscle volume for the knee extensors (P=0.04) and flexors (P=0.01) was 
significantly lower in patients with T2DM compared to controls (Table 2). There 
was no significant reduction in ankle plantar (P=0.23) and dorsiflexor (P=0.45) 
muscle volume in patients with T2DM compared to control subjects (Table 2). 
Intramuscular non-contractile tissue 
The IMNCT was significantly increased in the soleus (P= 0.006); dorsiflexor (P= 
0.005) and lateral gastrocnemius (P= 0.05) muscles in patients with T2DM 
12	  
	  
compared to controls (Table 2, Fig.1). There were no significant differences in 
IMNCT in the knee extensors or knee flexors between groups (Table 2). 
DSPN v No DSPN 
Patients with DSPN (n=8) had significantly lower knee extensor strength (Nm/kg) 
compared to patients without DSPN (n=12) (1.0±0.4 vs 1.5±0.4; P= 0.028). There 
was no significant difference in ankle plantar flexor strength between diabetic 
patients with and without DSPN (0.59±0.31 vs 0.76±0.19; P= 0.21). 
Low vs normal vitamin D 
There was no significant difference in muscle strength (1.2 ± 0.1 vs 1.3 ± 0.5; 
P=0.32) and volume (932.1 ± 427.3 vs 1122.7 ± 175.1; P=0.18) of the knee 
extensors and ankle plantar flexor strength (0.6 ± 0.2 vs 0.7 ± 0.2; P= 0.58) and 
volume (582.6 ± 306.9 vs 768.1 ± 160.5; P= 0.12) between diabetic patients with 
25OHD levels <25nmol/L compared to patients with 25OHD levels >25 nmol/L. 
Correlations 
There was a significant correlation between knee extensor strength and knee 
extensor muscle volume (r= 0.57; P= 0.007) in patients with T2DM. There was no 
significant correlation between ankle plantar flexor strength and ankle plantar 
flexor volume (r= 0.23, P= 0.297) or between knee and ankle muscle strength 
with IMNCT (r ranging from -0.34 to -0.02 at ankle and from -0.33 to 0.37 at 
knee), severity of DSPN (r= -0.36 at ankle and -0.48 at knee) or 25OHD levels 
(r= -0.12 at ankle and 0.13 at knee) among patients with Type 2 diabetes.  
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Discussion 
We have shown that patients with Type 2 diabetes mellitus have reduced 
proximal and distal lower limb muscle strength compared to age-matched 
controls, which is in agreement with other studies (2, 6, 7, 27). For the knee 
extensors, this was associated with muscle atrophy as reflected by the 
significantly reduced knee extensor muscle volume in patients with T2DM. In 
contrast, although the plantar flexor muscle strength was reduced in patients with 
T2DM, there was no measurable muscle atrophy. This may be attributed to the 
increase in intramuscular fat, which may ‘mask’ muscle atrophy. Essentially, 
since the muscle is infiltrated by increased levels of intramuscular fat, its CSA 
and volume appear ‘artificially’ larger than the actual active contractile area. The 
knee extensors demonstrated both a reduction in muscle strength and volume in 
patients with T2DM. The increase in intramuscular fat in the lower leg as 
opposed to the proximal knee extensors and flexors of patients with T2DM may 
well be related to peripheral neuropathy affecting the distal muscles. The exact 
mechanism that explains the association between an increase in intramuscular 
fat and peripheral neuropathy in patients with T2DM is not fully understood. An 
accumulation of IMNCT particularly in the thigh may further contribute to a 
reduction in muscle blood flow and insulin diffusion capacity, increasing the local 
concentration of fatty acids, resulting in insulin resistance of the skeletal muscle 
in patients with Type 2 DM (28). Aging is also associated with increased IMNCT 
within muscles of the lower limb in patients with Type 2 DM (29). 
 
We have found marked strength deficits not only in the ankle plantar flexors, 
which has been shown previously and related to DSPN, but also in proximal knee 
extensors, which may also be partly attributed to DSPN. Of clinical relevance, the 
knee extensors are a major antigravity muscle group responsible for propelling 
and controlling the body during gait and therefore this abnormality may partially 
explain the recent observation that balance is impaired in patients with diabetic 
neuropathy (30). Reduced ankle and knee muscle strength in patients with 
diabetes and particularly those with neuropathy may contribute substantially to 
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the impairment in gait, increased incidence of falls and severe injuries with 
hospitalisation. Indeed, resistance training exercises can improve muscle 
strength, walking speed and reduce the risk of falls (6, 31-33).  
Accumulation of IMNCT within skeletal muscle may result in insulin resistance, 
but has also been shown to correlate with reduced calf and thigh muscle strength 
in patients with DSPN (1). Magnetic resonance imaging allows accurate 
quantification of muscle CSA and volume and also allows one to differentiate 
muscle from fat, connective tissue and bone (34). In the present study knee 
extensor and flexor muscle volume was significantly smaller and there was also a 
trend for a smaller distal plantar flexor muscle volume in patients with T2DM. 
Muscle volume is of course associated with muscle strength and power 
production (14), in agreement with others (2, 6, 35). In addition to the impairment 
in lower extremity muscle function alterations in the cartilage, ligaments and 
tendons may also contribute to instability (36). Thus diabetes also increases the 
thickness of the Achilles tendon and plantar facia resulting in decreased flexibility 
of the ankle joint and limited dorsiflexion during walking (36). We have also found 
knee extensor muscle strength to be reduced significantly in patients with DSPN 
compared to those without DSPN. Previous studies have found that the severity 
of neuropathy contributes to an impairment of physical mobility (1). Thus the 
reduction in physical activity may result in a reduction in the use of the major 
antigravity muscles (37-39), particularly knee extensors during walking and this is 
reflected in the reduced strength of the knee extensors in patients with DSPN.   
 
Vitamin D deficiency causes musculoskeletal dysfunction and has been 
associated with a reduction in muscle strength, size, bone density and increased 
IMNCT (14, 27). Muscle weakness and atrophy are prominent in patients with 
diabetes (1, 2, 6, 7) and have been attributed to vitamin D deficiency (22, 23). To 
our knowledge this is the first study that has systematically examined differences 
in muscle function and structure in relation to vitamin D deficiency in patients with 
type 2TDM. Whilst we show that all diabetic patients have insufficient levels of 
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25(OH)D, a low level of 25OHD (<25 nmol/L) was not related to a reduction in 
lower limb muscle strength or size (15). 
The statistical power for the majority of key variables (muscle strength, size and 
IMNCT) in this study was 0.83-1, which is very high considering an optimal 
recommendation is 0.8 (40). Some other variables did fall below this optimal 0.8 
threshold and for some of these variables statistical power could have been 
limiting. Considering that we had such high power for the majority of key 
variables, the lower power for certain variables may also reflect the fact that no 
true differences exist between groups in these other variables and would not 
have been found even with a much larger sample.  
   
Conclusion 
This is a small but detailed study, which was adequately powered for the majority 
of variables examined. Potential confounders such as differences in BMI and 
ethnicity between groups may have an impact on our findings. However, patients 
with T2DM show both proximal (knee extensor) and distal (ankle plantar flexor) 
muscle weakness. Proximal muscle weakness was related to a reduction in 
muscle volume but distal muscle weakness was not. The latter finding may be as 
a consequence of greater infiltration of distal intramuscular fat. The reduction in 
muscle strength was related to DSPN but not to low levels of vitamin D. 
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Figure 
 
 
Figure 1. Representative lower limb MRI images from a healthy 69 year old 
control group volunteer (A and C) and a 67 year old patient with DPN (B and D). 
Images are from the mid-thigh level (A and B) and mid-tibia level (C and D). Note 
substantial increase in IMNCT (dark areas inside the muscle cross-sections are 
connective tissue) in images from patient with diabetes. Letters in A (VM: vastus 
medialis; VI: vastus intermedius; VL: vastus lateralis; FR: rectus femoris; BF: 
biceps femoris; ST: semitendinosus; SM: semimembranosus) and C (DF: 
Dorsiflexors; SOL: soleus; LG: lateral gastrocnemius MG: medial gastrocnemius) 
are abbreviations of muscle names in Latin. The length of the scale-bar along the 
left side of each image is 10 cm. 
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Tables 
  
Table1. Clinical characteristics of the participants. 
 
Parameter Control T2DM P-value 
No (male/female) 20(13/7) 20(15/5)  
DSPN (with/without) NA 8/12 NA 
Age (years) 61.5±6.0 63.1±10.8 0.56 
Height (m) 1.69±0.09 1.67±0.09 0.53 
Body mass (kg) 78.1±11.5 82.6±18.2 0.34 
BMI (kg/m2) 27.2±3.9 29.4±4.1 0.09 
Ethnicity (Asian/European) 
 
(9/11) (2/18)  
Duration of DM (years) NA 14.9 ± 9.9  
25OHD (nmol/L) 78.9±48.8 72.6±43.5 0.66 
25OHD/BMI 2.9±1.9 2.5±1.6 0.48 
25OHD/BSA  1.91±0.17 1.95±0.25 0.54 
HbA1c (%) NA 7.34±1.52 NA 
Cholesterol (mmol/l) NA 4.01±0.73 NA 
HDL (mmol/l) NA 1.37±0.887 NA 
LDL (mmol/l) NA 1.76±0.62 NA 
Triglycerides (mmol/l) NA 1.80±1.82 NA 
NDS (0-10) 0.4±1.0 3.1±2.6 0.000 
VPT(Hz) 6.4±3.0 14.7±11.0 0.003 
CT (Cº) NA 26.1±3.3 NA 
WT(ºC) NA 41.6±4.9 NA 
SNCV (m/s) NA 10.4±11.5 NA 
SNAP (μV) NA 5.2±10.7 NA 
PMNCV (m/s) NA 40.0±11.2 NA 
PMNAP (mV) NA 4.7±4.1 NA 
CNFD (no/mm2) NA 28.0±9.2 NA 
CNBD (no/mm2) NA 95.9±41.4 NA 
CNFL (mm/mm2) NA 23.6±8.57 NA 
CNFT (TC) NA 20.50±4.2 NA 
IENFD (no/mm) NA 7.8±5.4 NA 
DM: Diabetes mellitus; BMI: Body mass index; BSA: Body surface area; VD3: Vitamin D3; HbA1c: 
Glycated Haemoglobin; HDL:  High density lipoprotein; LDL: Low density lipoprotein; NDS: 
Neuropathy disability score; VPT: Vibration perception threshold; CT: Cold threshold; WT: Warm 
threshold; SNVC: Sural sensory nerve conduction velocity; SNAP: Sural sensory nerve amplitude; 
PMNCV: Peroneal motor nerve conduction velocity; PMNAP: Peroneal motor nerve amplitude; 
CNFD: Corneal nerve fiber density; CNBD: Corneal nerve branch density; CNFL: Corneal nerve 
fiber length; CNFT: Corneal nerve fiber tortuosity; IENFD: Intraepidermal nerve fiber density. 
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Table 2. Muscle strength, volume and IMNCT (MRI signal intensity values) in patients with T2DM 
and controls, with a-priori statistical power analysis, statistical difference and the percentage 
difference between groups. 
Variables Control T2DM  
Statistical 
power 
P-value % difference 
Muscle strength 
(Nm/kg) 
     
Knee extensors  1.9±0.7 1.3±0.5 
0.99 
0.003 -32 
Ankle plantar flexors 1.0±0.3 0.6±0.2 
1 
0.001 -34 
Muscle volume 
(cm3) 
     
MV SOL 418.7±114.8 420.2±132.4 
0.06 
0.97 0 
MV MG 184.8±52.8 170.3±68.5 
0.28 
0.46 -7 
MV LG 106.3±35.8 92.4±36.7 0.53 0.24 -13 
SUM Ankle PF 709.9±186.5 617.9±291.2 
0.53 
0.23 -12 
Ankle DF 218.2±49.9 205.3±55.3 
0.29 
0.45 -5 
MV VM 342.3±98.8 328.9±80.2 
0.16 
0.64 -3 
MV VI 342.3±106.4 293.1±62.8 
0.83 
0.08 -14 
MV VL 368.5±106.7 330.6±94.9 
0.51 
0.24 -10 
MV RF 148.5±47.8 117.5±48.7 
0.89 
0.05 -20 
Sum Knee 
extensors 
1201.6±323.2 968.4±395.6 
0.83 
0.04 -19 
MV SM 227.7±58.4 194.1±56.7 
0.83 
0.07 -14 
MV BF 288.4±77.3 246.4±68.3 
0.83 
0.08 -14 
MV ST 152.2±51.4 131.5±40.5 0.64 0.16 -13 
Sum Knee flexors 668.5±172.9 517.5±219.6 
0.96 
0.01 -22 
IMNCT (Pixel 
Intensity) 
     
Soleus 3453.3±356.0 3736.0±240.0 
1 
0.006 8 
MG 2751.8±325.3 2901.7±464.9 0.52 0.25 5 
LG 2039.6±282.5 2231.4±314.9 
0.89 
0.05 9 
DF 3748.7±321.8 4103.6±414.2 
1 
0.005 9 
VM 3628.4±138.3 3636.2±251.5 
0.07 
0.90 0 
VI 3553.8±155.2 3594.0±205.9 
0.26 
0.49 1 
24	  
	  
VL 3670.4±239.7 3668.1±349.6 
0.05 
0.98 -0 
RF 3303.1±206.1 3437.6±306.1 
0.76 
0.11 4 
SM 3571.3±342.5 3543.6±353.9 
0.10 
0.80 -0 
BF 3411.3±214.5 3457.9±276.9 
0.21 
0.56 1 
ST 3513.2±360.7 3715.4±427.9 
0.74 
0.12 5 
An independent sample t-test was used to represent the statistical differences in muscle strength, 
volume and intramuscular non-contractile tissue (IMNCT) in controls vs patients with diabetes 
(DM). SOL: soleus; DF: Dorsiflexors; PF: Plantar flexors; MG: medial gastrocnemius; LG: lateral 
gastrocnemius; VM: vastus medialis; VI: vastus intermedius; VL: vastus lateralis; RF: rectus 
femoris; SM: semimembranosus; BF: biceps femoris; ST: semitendinosus. 
 
